Skip to main content

Table 3 Predictors of regimen modification due to lipodystrophy

From: Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study

  HRa(95% CIb) P aHRc(95% CIb) P
Gender     
  Male 1   1  
  Female 2.05 (1.50-2.79) <0.001 2.11 (1.51-2.95) <0.001
Age     
  <35 1   1  
  ≥35 1.12 (0.83-1.51) 0.46 1.35 (0.98-1.84) 0.06
Clinical status     
  Asymptomatic 1   1  
  Symptomatic 0.88 (0.54-1.45) 0.62 0.81 (0.48-1.36) 0.43
  AIDS 0.65 (0.41-1.03) 0.07 0.72 (0.43-1.21) 0.21
CD4 cell count     
  >200 1   1  
  50-199 0.85 (0.46-1.57) 0.61 0.95 (0.50-1.80) 0.87
  <50 0.80 (0.43-1.46) 0.46 1.08 (0.56-2.07) 0.83
HLA-B*40:01     
  No 1   1  
  Yes 0.92 (0.64-1.32) 0.64 0.91 (0.62-1.32) 0.62
  1. aHR, hazard ratio.
  2. bCI, confidence interval.
  3. caHR, adjusted hazard ratio.